Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/17/2024 | Mkt Perform → Underperform | Raymond James | |
| 2/16/2024 | Outperform → Mkt Perform | Raymond James | |
| 6/14/2023 | $11.00 | Buy | Canaccord Genuity |
| 10/20/2021 | $7.50 | Buy | The Benchmark Company |
| 10/20/2021 | $7.50 | Buy | Benchmark |
CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, August 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (844) 763 8274 or 1 (647) 484 8814. The live audio webcast can be found on the investor sect
CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal third quarter 2024 financial results on Wednesday, August 14, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, August 15, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free: 1 (844) 763 8274 International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of t
• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid ("NCIB") Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, May 16, 2024, at 10:
6-K - Quipt Home Medical Corp. (0001540013) (Filer)
6-K - Quipt Home Medical Corp. (0001540013) (Filer)
6-K - Quipt Home Medical Corp. (0001540013) (Filer)
CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, August 15, 2024, at 10:00 a.m. (ET). The dial-in number is 1 (844) 763 8274 or 1 (647) 484 8814. The live audio webcast can be found on the investor sect
CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal third quarter 2024 financial results on Wednesday, August 14, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, August 15, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free: 1 (844) 763 8274 International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of t
• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid ("NCIB") Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand. Quipt will host its Earnings Conference Call on Thursday, May 16, 2024, at 10:
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)
Benchmark analyst Bill Sutherland maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $10 to $9.
Canaccord Genuity analyst Richard Close maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $9 to $8.
Quipt Home Medical (NASDAQ:QIPT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.01 by 400 percent. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $64.000 million which missed the analyst consensus estimate of $65.590 million by 2.42 percent. This is a 10.12 percent increase over sales of $58.120 million the same period last year.
Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform
Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform
Canaccord Genuity resumed coverage of Quipt Home Medical with a rating of Buy and set a new price target of $11.00
CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme
CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio